20 Dec 2021 argenx announces U.S. Food and Drug Administration (FDA) approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis Member news
01 Dec 2021 QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences Member news
25 Nov 2021 FIT and its 21-strong partner team go all out for more internationalization, growth and prosperity Multiple categories
16 Nov 2021 New study demonstrates Idylla™ EGFR Mutation Test (CE-IVD) shortens time to patient management decisions for patients with non-small cell lung cancer Member news
15 Nov 2021 Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
